Ionis’ drug, called sapablursen, is currently being tested in a Phase 2 trial in people with polycythemia vera.

Ionis Pharmaceuticals Inc (NASDAQ:IONS) and Ono Pharmaceutical Co., Ltd entered into a license agreement in which Ono obtains ...

Consolidated net revenues totaled $372.0 million for the fiscal year Financial condition remains strong with no debt and approximately $30 million in cash Management provides guidance for fiscal year ...

New tenants are opening and existing tenants are expanding at Crocker Park lifestyle center in Westlake, a western suburb of Cleveland. New tenants include Color Me Mine, Garage, Océanne, State & ...

Ionis will receive $280 million upfront and could get up to $660 million in future milestone payments. Ono will take charge ...

FORT WAYNE, Ind., March 12, 2025 (GLOBE NEWSWIRE) -- Vera Bradley, Inc. (Nasdaq: VRA) (the "Company”) today announced its ...

Vera Bradley Inc. (VRA) on Wednesday reported a loss of $47 million in its fiscal fourth quarter. The Roanoke, Indiana-based company said it had a loss of $1.

Vera Bradley reported lower revenue in the fourth quarter and said it signed a deal to sell its Pura Vida business, one of ...

This Holi, the festival of colours you love to celebrate, celebrate with full enthusiasm without fearing of any damage of ...

Holi color can brighten your festival but is tough on the skin. Find out which are the best cleansers for face to remove the ...

CRISTIANO RONALDO and Rafael Nadal’s business has shut unexpectedly after just three years. The pair jointly invested in an ...

Rep. Andrew Garbarino (R., N.Y.), chairman of the House Homeland Security Committee's subcommittee on cybersecurity and infrastructure protection, said the change in administration and leadership at ...